Original articleAlimentary tractFactors That Increase Risk of Celiac Disease Autoimmunity After a Gastrointestinal Infection in Early Life
Section snippets
Study Cohort
The TEDDY study, approved by local Ethical Institutional Review Boards and monitored by an External Advisory Board formed by the National Institutes of Health, follows up a birth cohort of 8676 children with 1 of 10 HLA-DR-DQ genotypes associated with type 1 diabetes and/or celiac disease,8 located in Finland; Germany; and Sweden; and Colorado, Georgia/Florida, and Washington state in the United States.9 Of the infants enrolled, 8280 (95.4%) carried one of the following HLA genotypes:
Temporal Association Between Infectious Episodes and Risk of Celiac Disease Autoimmunity
Complete demographic and dietary information was available for 97.2% (6148 of 6327) of subjects (Table 1). A total of 13,881 GIEs and 79,816 RIEs were recorded during the study period. RIEs and GIEs peaked between 6 and 9 months of age (69.7% of children reporting) and 15 to 18 months of age (18.2% of children reporting), respectively (Supplementary Figure 3A). The incidence of RIEs and GIEs was highest in February (5.0 and 1.09 per person-years, respectively) and lowest in July (1.6 and 0.32
Discussion
In TEDDY, gastrointestinal infections occurring 3 months before the seroconversion period may trigger CDA in children carrying HLA risk genotypes for celiac disease. The increased risk after a gastrointestinal infection is modified further by several early life factors including the duration of any breastfeeding, age of gluten introduction, season of birth, HLA genotype, and status of rotavirus vaccination, pointing to important interactions between diet and infections in the development of CDA
Conclusions
A gastrointestinal infection increases CDA risk in the following 3-month period in children at genetic risk for celiac disease. The timing of infection is important and its effect on CDA risk is modified further by early introduction to gluten in children born in winter, short duration of any breastfeeding in non-DQ2 risk carriers, and status of rotavirus vaccination. This indicates that various exposures during early childhood may trigger CDA and encourages further work on the role of viruses,
References (23)
- et al.
Gastroenteritis in childhood: a retrospective study of 650 hospitalized pediatric patients
Int J Infect Dis
(2011) - et al.
Early infections are associated with increased risk for celiac disease: an incident case-referent study
BMC Pediatr
(2012) - et al.
Association of maternal education, early infections, and antibiotic use with celiac disease: a population-based birth cohort study in northeastern Italy
Am J Epidemiol
(2014) - et al.
Infections and risk of celiac disease in childhood: a prospective nationwide cohort study
Am J Gastroenterol
(2015) - et al.
Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study
Am J Gastroenterol
(2006) - et al.
Infectious disease and risk of later celiac disease in childhood
Pediatrics
(2010) - et al.
Coeliac disease is associated with intrauterine growth and neonatal infections
Acta Paediatr
(2002) - et al.
Risk of pediatric celiac disease according to HLA haplotype and country
N Engl J Med
(2014) - et al.
TEDDY–The Environmental Determinants of Diabetes in the Young: an observational clinical trial
Ann N Y Acad Sci
(2006) - et al.
The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants
Pediatr Diabetes
(2011)
The Environmental Determinants of Diabetes in the Young (TEDDY) study: study design
Pediatr Diabetes
Cited by (143)
Coeliac disease: what can we learn from prospective studies about disease risk?
2024, The Lancet Child and Adolescent HealthAcid Suppression and Antibiotics Administered during Infancy Are Associated with Celiac Disease
2023, Journal of PediatricsGut virome in early life: origins and implications
2022, Current Opinion in VirologyGut microbiota in celiac disease
2024, Annals of Gastroenterology
Conflicts of interest The authors disclose no conflicts.
Funding This study was funded by U01 DK63829, U01 DK63861, U01 DK63821, U01 DK63865, U01 DK63863, U01 DK63836, U01 DK63790, UC4 DK63829, UC4 DK63861, UC4 DK63821, UC4 DK63865, UC4 DK63863, UC4 DK63836, UC4 DK95300, UC4 DK100238, and UC4 DK106955 grants from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and contract HHSN267200700014C from the National Institutes of Health (NIH), as well as the National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Child Health and Human Development (NICHD), National Institute of Environmental Health Sciences (NIEHS), Juvenile Diabetes Research Foundation (JDRF), and the Centers for Disease Control and Prevention (CDC). This work was supported in part by the National Center for Advancing Translational Sciences (NCATS) Clinical and Translational Science Awards to the University of Florida (UL1 TR000064) and the University of Colorado (UL1 TR001082).